New drug extends multiple sclerosis options 25/11/2004 - The first in a completely new class of drug for multiple sclerosis has been approved in the US, opening up a new avenue of treatment for sufferers of the debilitating diseases and potential blockbuster revenues for developers Elan and Biogen 